BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15675955)

  • 1. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes.
    Nin M; Katoh N; Kokura S; Handa O; Yoshikawa T; Kishimoto S
    J Dermatol Sci; 2009 Apr; 54(1):17-24. PubMed ID: 19118981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.
    Descargues P; Deraison C; Prost C; Fraitag S; Mazereeuw-Hautier J; D'Alessio M; Ishida-Yamamoto A; Bodemer C; Zambruno G; Hovnanian A
    J Invest Dermatol; 2006 Jul; 126(7):1622-32. PubMed ID: 16628198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
    Raghunath M; Tontsidou L; Oji V; Aufenvenne K; Schürmeyer-Horst F; Jayakumar A; Ständer H; Smolle J; Clayman GL; Traupe H
    J Invest Dermatol; 2004 Sep; 123(3):474-83. PubMed ID: 15304086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
    Hachem JP; Wagberg F; Schmuth M; Crumrine D; Lissens W; Jayakumar A; Houben E; Mauro TM; Leonardsson G; Brattsand M; Egelrud T; Roseeuw D; Clayman GL; Feingold KR; Williams ML; Elias PM
    J Invest Dermatol; 2006 Jul; 126(7):1609-21. PubMed ID: 16601670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
    Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
    Hovnanian A
    Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.
    Tartaglia-Polcini A; Bonnart C; Micheloni A; Cianfarani F; Andrè A; Zambruno G; Hovnanian A; D'Alessio M
    J Invest Dermatol; 2006 Feb; 126(2):315-24. PubMed ID: 16374478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
    Komatsu N; Takata M; Otsuki N; Ohka R; Amano O; Takehara K; Saijoh K
    J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
    Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
    Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
    Igawa S; Kishibe M; Minami-Hori M; Honma M; Tsujimura H; Ishikawa J; Fujimura T; Murakami M; Ishida-Yamamoto A
    J Invest Dermatol; 2017 Feb; 137(2):449-456. PubMed ID: 27769847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEKTI-1 in sickness and in health.
    Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
    Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
    J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
    Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
    J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
    Deraison C; Bonnart C; Lopez F; Besson C; Robinson R; Jayakumar A; Wagberg F; Brattsand M; Hachem JP; Leonardsson G; Hovnanian A
    Mol Biol Cell; 2007 Sep; 18(9):3607-19. PubMed ID: 17596512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
    Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
    J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.